14.11.2012 Views

Program Book

Program Book

Program Book

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

2226 RES 4<br />

NOTCH SIGNALING PROMOTES UVEAL MELANOMA<br />

GROWTH<br />

Eberhart Charles, Ebrahimi Katayoon, Schreck Karisa, Bar Eli, Harbour J,<br />

William Handa, James, Merbs Shannath, Asnaghi Laura (ceberha@jhmi.edu)<br />

Departments of Pathology, Ophthalmology and Oncology, Johns Hopkins<br />

University, School of Medicine, Baltimore, MD, USA<br />

Department of Ophthalmology & Visual Sciences, Washington University<br />

School of Medicine, St. Louis, MO, USA<br />

Purpose. To determine if uveal melanoma requires Notch activity for<br />

growth and metastasis.<br />

Methods. Expression of Notch pathway members was characterized<br />

in primary tumor samples and in cell lines using Western blots, real<br />

time RT PCR and gene expression arrays. Notch inhibition was achieved<br />

using small molecule inhibitors and shRNA constructs targeting multiple<br />

pathway members. Notch signaling was induced with constitutively active<br />

truncated receptors. Growth, invasion and clonogenicity were measured<br />

in vitro using standard assays, and in vivo xenografts were examined<br />

histopathologically.<br />

Results. Notch receptors, ligands and targets were expressed in all five cell<br />

lines examined, and in 30 primary uveal melanoma samples. Interestingly,<br />

the three lines with high levels of baseline pathway activity (OCM1, OCM3,<br />

OCM8) had their growth reduced by pharmacologic Notch blockade using<br />

the gamma-secretase inhibitor (GSI) MRK003. In contrast, two uveal<br />

melanoma lines (Mel285, Mel290) with very low expression of Notch<br />

targets were insensitive to the GSI. Constitutively active forms of Notch1<br />

and Notch2 promoted growth of uveal melanoma cultures and were able<br />

to rescue the inhibitory effects of GSI. MRK003 treatment also inhibited<br />

anchorage-independent clonogenic growth and cell invasion, and reduced<br />

phosphorylation levels of Akt and Erk1/2. Suppression of canonical Notch<br />

activity using shRNA targeting Notch2 or CBF1 was also able to reduce<br />

tumor growth and invasion. Notch signaling was required to maintain<br />

Twist1 expression in uveal melanoma cells, and Twist1 knockdown using<br />

shRNA reduced invasion. Finally, intraocular xenograft growth was<br />

significantly reduced by GSI treatment.<br />

Conclusions. Our findings suggest that Notch plays an important role in<br />

inducing proliferation and invasion in uveal melanoma, and that inhibiting<br />

this pathway may be effective in preventing tumor growth and metastasis.<br />

Financial disclosure. None<br />

1624 RES 5<br />

IN VIVO CONTRAST-ENHANCED HIGH-FREQUEN-<br />

CY ULTRASONOGRAPHY OF UVEAL MELANOMA<br />

IN ANIMAL MODELS: IMAGING FEATURES AND<br />

HISTOPATHOLOGIC CORRELATIONS<br />

Hans E. Grossniklaus1, Qing Zhang1, Hua Yang1, Shin J Kang1, Yanggan<br />

Wang1, Tonya Coulthard2 (ophtheg@emory.edu)<br />

1. Emory University School of Medicine, Atlanta, Georgia<br />

2. Visual Sonics, Toronto, Canada<br />

Purpose. To evaluate the utility of in vivo imaging of a mouse model<br />

of uveal melanoma utilizing high-frequency contrast-enhanced<br />

ultrasound (HF-CE-US) with 2- or 3-dimensional modes, and to correlate<br />

the sonographic findings with histopathologic characteristics.<br />

Methods. Fourteen 12-week-old C57BL6 mice were inoculated into<br />

RESEARCH DAY<br />

Abstracts<br />

19<br />

their right eyes with aliquots of 5X105/2.5µL of B16LS9 melanoma<br />

cells, and randomly assigned into 2 groups. At 7 days post inoculation,<br />

tumor-bearing eyes in group 1 (n = 8) were imaged using high<br />

frequency ultrasound with microbubble contrast agent to determine<br />

the 2-dimensional tumor size and relative blood volume; eyes in<br />

group 2 (n = 6) were imaged by 3-dimensional mode ultrasound with<br />

microbubble enhancement, and the tumor volume was determined.<br />

Histologic tumor burden was quantified in enucleated tumor-bearing<br />

eyes by Image J software, and microvascular density was determined<br />

by counting vWF-positive vascular channels. The 2D or 3D in vivo<br />

imaging were evaluated and compared with histopathologic findings.<br />

A rabbit model of ocular melanoma was also evaluated.<br />

Results. Utilizing high frequency ultrasound with microbubble contrast<br />

agent in the mouse model, melanomas were visualized as relatively<br />

hyperechoic regions in the images. The intraobserver variability was<br />

9.65 ± 7.89% and the coefficient of variation for multiple measurements<br />

was 7.33 ± 5.71%. The correlation coefficient of sonographic volume or<br />

size and histologic area was 0.71 (P = 0.11) and 0.79 (P = 0.32). The<br />

relative blood volume within the tumor demonstrated sonographically<br />

with the contrast agent correlated signficantly with histologic tumor<br />

vascularity (r = 0.83, P < 0.001). Intraturmor vasularization/blood<br />

volume was also demonstrated in the rabbit model.<br />

Conclusions. There is a positive linear correlation between in vivo<br />

sonographic tumor volume/size and histologic tumor size in our mouse<br />

ocular melanoma model. Contrast-enhanced intensity corresponds with<br />

microvascular density and blood volume in the model. High frequency<br />

ultrasound with microbubble contrast enhancement is a real-time,<br />

non-invasive and reliable method for in vivo evaluation of experimental<br />

intraocular melanoma tumor area and relative blood volume.<br />

Financial disclosure. Visual Sonices (TC)<br />

21 RES 6<br />

HISTOPATHOLOGICAL AND DOSIMETRIC FINDINGS<br />

IN A PORCINE MODEL OF OCULAR RADIATION INJURY<br />

FROM IODINE-125 PLAQUE BRACHYTHERAPY<br />

Scott C. N. Oliver, MD, Victor Hsu, BA, Lucy Bollinger, Moyed Miften,<br />

PhD, Laurie Gaspar, MD, Philip Boyer, MD (scott.oliver@ucdenver.edu)<br />

Departments of Ophthalmology, Radiation Oncology and Pathology,<br />

University of Colorado School of Medicine<br />

Purpose. An animal model for acute radiation injury to the eye does<br />

not exist. This study sought to describe the histopathological and<br />

dosimetric findings in a porcine model of ocular radiation injury<br />

from Iodine-125 (I-125) plaque brachytherapy.<br />

Methods. The eyes from six pigs were irradiated with a high<br />

dose of I-125 radiation (125-140 Gy), with progressively<br />

lengthening survival durations of 1 to 11 weeks. Intraoperative<br />

thermoluminescent dosimetry was compared to theoretical dose<br />

calculations at five points along the globe. Sectioned eyes were<br />

analyzed to determined histopathologic markers of acute radiation<br />

injury.<br />

Results. High-dose plaque brachytherapy in a porcine model was<br />

technically feasible and well tolerated. Dosimetric measurements<br />

demonstrated unacceptable variability and reproducibility when<br />

oriented in a radial direction due to difficulty in positioning the<br />

detectors on the posterior half of the globe. Equatorial orientation<br />

of the dosimeters resulted in reliable measurements in close<br />

agreement with theoretical dose calculations. Histopathological<br />

evidence of acute radiation injury to the eye was detectable as

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!